.After antibody-drug conjugate (ADC) specialist Seagen was marketed to Pfizer in 2014 for a monstrou...
.On the heels of a period 3 gain that fell short to blow away clients, Ironwood Pharmaceuticals is b...
.Don't quit Monte Rosa Therapeutics right now. The Boston-based biotech is having a ball after signi...
.Accept to this week's Chutes & Ladders, our summary of considerable leadership hirings, shooting...
.Commemorating his firm's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer sounded ...
.AbbVie has come back to the resource of its own antipsychotic powerhouse Vraylar trying to find an ...
.GenSight Biologics is full weeks off of running out of amount of money. Once again. The biotech mer...
.Monopar Therapeutics is bouncing back a medicine coming from the dump of AstraZeneca's unusual ailm...
.With brand new records out on Arcus Biosciences' speculative HIF-2a prevention, one group of profes...
.After forming a gene treatment collaboration with Dyno Therapeutics in 2020, Roche is actually back...